The rare kidney disorders market is projected to grow at a CAGR of 17%, during the period 2022-2035, claims Roots Analysis Considering the rising unmet need associated with rare kidney disorders and the growing adoption of available treatment options, industry stakeholders have made significant investments to enable the development of novel drug candidates targeting this set of rare diseases. For additional details, please visit https://www.rootsanalysis.com/reports/rare-kidney-diseases-market.html